Table 1 Characteristics of the patients enrolled in the study.

From: The impact of COVID-19-related quarantine on psychological outcomes in patients after cardiac intervention: a multicenter longitudinal study

 

Quarantine group

Control group

t/χ2

p

 

(n = 73)

(n = 76)

  

Demographic characteristics

    

 Age (years)

62.71 (10.22)

61.28 (10.23)

−0.86

0.393

 Sex, male (N, %)

60 (82)

69 (91)

1.69

0.194

 Education (years)

12.38 (4.22)

13.07 (4.32)

0.97

0.331

Type of cardiac intervention

  

2.33

0.127

 Surgery (N, %)

20 (27)

12 (16)

 Procedure (N, %)

53 (73)

64 (84)

 Days since surgery

33.52 (39.97)

26.64 (19.08)

−1.33

0.186

Cardiac risk factors

    

 Hypertension (N, %)

56 (77)

54 (71)

0.36

0.549

 Atrial fibrillation (N, %)

20 (27)

17 (22)

0.27

0.603

 Diabetes (N, %)

11 (15)

12 (16)

0.001

0.999

 Dyslipidemia (N, %)

39 (53)

45 (59)

0.30

0.585

 CCI score

2.70 (1.25)

2.59 (1.34)

−0.50

0.617

Medications

    

 β-blockers (N, %)

57 (78)

64 (84)

0.56

0.455

 Antihypertensives (N, %)

29 (40)

23 (30)

1.08

0.299

 Antiarrhythmics (N, %)

14 (19)

7 (9)

2.29

0.130

 Anticoagulants (N, %)

71 (97)

76 (100)

0.55

0.459

 ACE-inhibitors (N, %)

31 (42)

39 (51)

0.84

0.359

 Psychiatric drugs (N, %)

4 (5)

2 (3)

0.22

0.640

Biomedical and behavioral characteristics

   

 Systolic Blood Pressure (mmHg)

127.40 (15.48)

129.71 (14.87)

0.85

0.394

 Diastolic Blood Pressure (mmHg)

77.37 (7.45)

77.79 (7.13)

0.33

0.744

 BMI (kg/m2)

26.10 (2.94)

26.64 (3.59)

0.99

0.323

 Walking (total minutes in the last week)

194.52 (185.56)

242.93 (199.49)

1.53

0.127

  1. Data are the M (SD) of continuous variables and the N (%) of categorical variables.
  2. BMI body mass index, CCI age-adjusted Charlson Comorbidity Index, ACE- inhibitors angiotensin-converting-enzyme inhibitors.